The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Update

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the recipient of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 13,500 shares, a growth of 17.4% from the February 13th total of 11,500 shares. Based on an average daily volume of 30,900 shares, the days-to-cover ratio is currently 0.4 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Trading Down 0.6 %

Shares of CGABL stock opened at $17.78 on Friday. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a fifty-two week low of $17.48 and a fifty-two week high of $20.85. The stock has a 50 day moving average price of $18.10 and a two-hundred day moving average price of $18.91.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Saturday, February 15th. Stockholders of record on Saturday, February 1st were paid a dividend of $0.2891 per share. The ex-dividend date was Friday, January 31st. This is a boost from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29. This represents a $1.16 annualized dividend and a dividend yield of 6.50%.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.